|
|
|
|
|
|
Ptc Therapeutics Cmn (PTCT)
|
|
12.75 +0.17 (+1.35%)
|
5/25/2017 4:00pm
|
|
Open:
|
12.90
|
Pre. Close:
|
12.58
|
|
High:
|
12.98
|
Low:
|
12.52
|
|
Volume:
|
613,642
|
Market Cap:
|
437.53M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
13.13 - 13.68
|
13.68 - 14.11
|
|
Low:
|
11.98 - 12.21
|
12.21 - 12.39
|
|
Close:
|
12.39 - 13.03
|
13.03 - 13.52
|
|
|
|
|
|
|
Technical analysis (as of: 2017-05-25 4:48:52 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
|
|
Target:
|
Six months: 16.18 One year: 18.89
|
|
Support:
|
Support1: 11.87 Support2: 10.65
|
|
Resistance:
|
Resistance1:
13.85 Resistance2: 16.18
|
|
Pivot:
|
12.77
|
|
Moving Averages:
|
MA(5): 13.17  MA(20): 12.63
MA(100): 11.96 MA(250): 10.18
|
|
MACD:
|
MACD(12,26):
0.51 Signal(12,26,9): 0.57
|
|
%K %D:
|
%K(14,3): 71.67 %D(3): 79.92
|
|
RSI:
|
RSI(14): 54.89
|
|
52-Week:
|
High: 16.50
Low: 4.03 Change(%): 62.6
|
|
Average Vol(K):
|
3-Month: 1285
10-Days 624
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.PTCT has closed above bottom band by 49.2%. Bollinger Bands are 14.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Tue, 23 May 2017 12:00:00 GMT
New Analysis of ACT DMD Placebo Data on Corticosteroids Presented at ...
Wed, 07 Dec 2016 21:42:20 GMT
PTC Therapeutics, Inc. in 3 Charts
Thu, 16 Mar 2017 13:30:54 GMT
PTC Therapeutics will buy Marathon Pharma's controversial DMD drug for $75 mln ...
Mon, 08 May 2017 11:26:15 GMT
PTC Therapeutics Reports First Quarter 2017 Financial Results and Provides ...
Thu, 02 Mar 2017 17:03:45 GMT
Why PTC Therapeutics Is Plunging Today
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
